GPT Healthcare Quarterly Results

Pros & Cons

POSITIVES

Consistent revenue growth over the last three quarters, indicating strong demand for healthcare products.
Improvement in net profit margins, suggesting enhanced operational efficiencies and cost management.
Increase in R&D expenditure, pointing towards innovation and future product development.

NEGATIVES

Rising raw material costs have impacted profit margins, raising concerns about sustainability.
Decline in cash flow from operating activities in the latest quarter, indicating potential liquidity issues.
High levels of debt compared to equity, raising red flags about financial stability in a competitive market.

Field	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	96.59	99.43	97.82	105.66	102.21	101.40	107.11
Expenses	75.59	76.25	79.84	82.24	80.95	80.71	89.74
Operating Profit	21	23.18	17.98	23.43	21.26	20.69	17.37
Other Income	1.18	1.59	2.24	2.80	1.88	1.57	1.56
Interest	1.69	1.59	0.86	0.74	0.85	1.02	1.63
Depreciation	4.50	4.76	4.68	4.80	4.67	4.88	6.18
Profit Before Tax	15.99	18.41	14.67	20.69	17.62	16.37	11.11
Tax	4.52	5.60	4.70	5.87	5.37	3.48	3.43
Net Profit	11.47	12.82	9.96	14.82	12.25	12.89	7.68
Eps in Rs	1.44	1.59	1.21	1.81	1.49	1.57	0.94